Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Belsomra
No generic version of Belsomra is currently available. The drug, approved by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia, is manufactured by Merck & Co. [1].
The earliest a generic version of Belsomra could become available depends on patent expirations and any potential legal challenges. Information regarding Belsomra's patent status and exclusivity periods can be found on DrugPatentWatch.com [2].
Belsomra (suvorexant) is a medication prescribed to help individuals fall asleep and stay asleep [1]. It works by blocking the action of orexins, which are chemicals in the brain that promote wakefulness [1].
Common side effects of Belsomra include drowsiness, dizziness, and unusual dreams. Patients may also experience sleep paralysis, hallucinations, and suicidal thoughts. It is important for patients to discuss any concerns or potential side effects with their healthcare provider [1].
Other Questions About Belsomra :